220 related articles for article (PubMed ID: 26295143)
1. Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
Qi R; Majoros I; Misra AC; Koch AE; Campbell P; Marotte H; Bergin IL; Cao Z; Goonewardena S; Morry J; Zhang S; Beer M; Makidon P; Kotlyar A; Thomas TP; Baker JR
J Biomed Nanotechnol; 2015 Aug; 11(8):1431-41. PubMed ID: 26295143
[TBL] [Abstract][Full Text] [Related]
2. Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
Thomas TP; Huang B; Choi SK; Silpe JE; Kotlyar A; Desai AM; Zong H; Gam J; Joice M; Baker JR
Mol Pharm; 2012 Sep; 9(9):2669-2676. PubMed ID: 22827500
[TBL] [Abstract][Full Text] [Related]
3. Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.
Thomas TP; Goonewardena SN; Majoros IJ; Kotlyar A; Cao Z; Leroueil PR; Baker JR
Arthritis Rheum; 2011 Sep; 63(9):2671-80. PubMed ID: 21618461
[TBL] [Abstract][Full Text] [Related]
4. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
Thomas TP; Majoros IJ; Kotlyar A; Kukowska-Latallo JF; Bielinska A; Myc A; Baker JR
J Med Chem; 2005 Jun; 48(11):3729-35. PubMed ID: 15916424
[TBL] [Abstract][Full Text] [Related]
5. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.
Myc A; Douce TB; Ahuja N; Kotlyar A; Kukowska-Latallo J; Thomas TP; Baker JR
Anticancer Drugs; 2008 Feb; 19(2):143-9. PubMed ID: 18176110
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis.
Zhao J; Zhao M; Yu C; Zhang X; Liu J; Cheng X; Lee RJ; Sun F; Teng L; Li Y
Int J Nanomedicine; 2017; 12():6735-6746. PubMed ID: 28932117
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio.
Zong H; Thomas TP; Lee KH; Desai AM; Li MH; Kotlyar A; Zhang Y; Leroueil PR; Gam JJ; Banaszak Holl MM; Baker JR
Biomacromolecules; 2012 Apr; 13(4):982-91. PubMed ID: 22360561
[TBL] [Abstract][Full Text] [Related]
8. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis.
Wu Z; Xu K; Min J; Chen M; Shen L; Xu J; Jiang Q; Han G; Pan L; Li H
J Appl Biomater Funct Mater; 2020; 18():2280800020962629. PubMed ID: 33155513
[TBL] [Abstract][Full Text] [Related]
9. Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles.
Silpe JE; Sumit M; Thomas TP; Huang B; Kotlyar A; van Dongen MA; Banaszak Holl MM; Orr BG; Choi SK
ACS Chem Biol; 2013 Sep; 8(9):2063-71. PubMed ID: 23855478
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate and sulforaphane loaded PBA-G5-PAMAM dendrimers as a combination therapy for anti-inflammatory response in an intra-articular joint arthritic animal model.
Essien EN; Revi N; Khatri V; Liu S; Van Thiel G; Bijukumar D
Int J Pharm; 2023 Jul; 642():123150. PubMed ID: 37336302
[TBL] [Abstract][Full Text] [Related]
11. PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic.
Huang B; Otis J; Joice M; Kotlyar A; Thomas TP
Biomacromolecules; 2014 Mar; 15(3):915-23. PubMed ID: 24392665
[TBL] [Abstract][Full Text] [Related]
12. Folate-Modified Poly(malic acid) Graft Polymeric Nanoparticles for Targeted Delivery of Doxorubicin: Synthesis, Characterization and Folate Receptor Expressed Cell Specificity.
Yang Y; Li N; Nie Y; Sheng M; Yue D; Wang G; Tang JZ; Gu Z
J Biomed Nanotechnol; 2015 Sep; 11(9):1628-39. PubMed ID: 26485931
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-loaded folic acid of solid-phase synthesis conjugated gold nanoparticles targeted treatment for rheumatoid arthritis.
Li X; Wang H; Zou X; Su H; Li C
Eur J Pharm Sci; 2022 Mar; 170():106101. PubMed ID: 34936935
[TBL] [Abstract][Full Text] [Related]
14. Poly(amidoamine) dendrimer-methotrexate conjugates: the mechanism of interaction with folate binding protein.
van Dongen MA; Rattan R; Silpe J; Dougherty C; Michmerhuizen NL; Van Winkle M; Huang B; Choi SK; Sinniah K; Orr BG; Banaszak Holl MM
Mol Pharm; 2014 Nov; 11(11):4049-58. PubMed ID: 25222480
[TBL] [Abstract][Full Text] [Related]
15. Bioanalytical method development for a generation 5 polyamidoamine folic acid methotrexate conjugated nanoparticle.
van Haandel L; Stobaugh JF
Anal Bioanal Chem; 2010 Jul; 397(5):1841-52. PubMed ID: 20431871
[TBL] [Abstract][Full Text] [Related]
16. Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.
Zhang Y; Thomas TP; Desai A; Zong H; Leroueil PR; Majoros IJ; Baker JR
Bioconjug Chem; 2010 Mar; 21(3):489-95. PubMed ID: 20128612
[TBL] [Abstract][Full Text] [Related]
17. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
18. Substrate-Triggered Exosite Binding: Synergistic Dendrimer/Folic Acid Action for Achieving Specific, Tight-Binding to Folate Binding Protein.
Chen J; van Dongen MA; Merzel RL; Dougherty CA; Orr BG; Kanduluru AK; Low PS; Marsh EN; Banaszak Holl MM
Biomacromolecules; 2016 Mar; 17(3):922-7. PubMed ID: 26815158
[TBL] [Abstract][Full Text] [Related]
19. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
[TBL] [Abstract][Full Text] [Related]
20. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
He R; Yin C
Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
